In a lung multicellular tumor spheroid (MTS) model, the GSK-3β inhibitor CHIR-99021 significantly increases the expression of CD31 and VE-cadherin, while inhibiting the expression of α-SMA and vimentin in HUVEC cells [65]. This evidence concerns the gene ACTA1 and neoplasm.